Cornerstone Pharmaceuticals focuses on advancing innovative cancer therapies targeting some of the most challenging forms of the disease, such as acute myeloid leukemia (AML), Burkitt's lymphoma, and pancreatic cancer. The company is dedicated to developing effective treatments that aim to improve patient outcomes and quality of life.
Specialties
Innovative cancer therapies
Targeting mitochondrial function
Orphan drug development
Clinical trials for AML
Focus on complex cancers
Products & Services
Cancer therapies
Clinical trials
Orphan drug designation
Innovative treatments
Biotechnology solutions
Contact Information
No contact information available
Competitors & Similar Companies(10)
Amgen Inc.
California, • United States
Gilead Sciences, Inc.
California, • United States
Regeneron Pharmaceuticals, Inc.
New York, • United States
Sierra Oncology
British Columbia, • Canada
Blueprint Medicines Corporation
Massachusetts, • United States
Novartis AG
Basel-City, • Switzerland
Catalyst Pharmaceuticals, Inc.
Florida, • United States
Mirati Therapeutics, Inc.
California, • United States
Zymeworks Inc.
British Columbia, • Canada
Trevena, Inc.
News & Media
Search Terms:
cornerstone pharmaceuticals
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Cornerstone Pharmaceuticals
Where is Cornerstone Pharmaceuticals located?
The headquarter of Cornerstone Pharmaceuticals is located in Cranbury, New Jersey, United States
What is the official website of Cornerstone Pharmaceuticals?
What industry does Cornerstone Pharmaceuticals belong to?
Cornerstone Pharmaceuticals belongs to the Biotechnology and Life Sciences industry.
What are the specialties of Cornerstone Pharmaceuticals?
Cornerstone Pharmaceuticals specializes in Innovative cancer therapies, Targeting mitochondrial function, Orphan drug development, Clinical trials for AML, Focus on complex cancers.
What products and services is Cornerstone Pharmaceuticals likely to offer?
Cornerstone Pharmaceuticals offers Cancer therapies, Clinical trials, Orphan drug designation, Innovative treatments, Biotechnology solutions.
Who are the competitors of Cornerstone Pharmaceuticals?
Competitors of Cornerstone Pharmaceuticals are Amgen Inc., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., Sierra Oncology, Blueprint Medicines Corporation, Novartis AG, Catalyst Pharmaceuticals, Inc., Mirati Therapeutics, Inc., Zymeworks Inc., Trevena, Inc..
What does Cornerstone Pharmaceuticals do?
Cornerstone Pharmaceuticals focuses on advancing innovative cancer therapies targeting some of the most challenging forms of the disease, such as acute myeloid leukemia (AML), Burkitt's lymphoma, and pancreatic cancer. The company is dedicated to developing effective treatments that aim to improve patient outcomes and quality of life.
What are the social media links of Cornerstone Pharmaceuticals?